Sleep apnea isn’t just something that affects older adults anymore. Experts say they’re seeing more younger people being ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Sleep apnea often goes untreated because it doesn’t look the way most people expect it to. Many imagine loud, disruptive ...

Obstructive Sleep Apnea (OSA) is a common but often undiagnosed medical condition affecting many Canadians. Characterized by ...

Sleep problems are expanding quickly among children because of inconsistent school schedules and more screen time. Disrupted ...

Graham Goodrich, CCO, Apnimed, outlines how advances in diagnostics, growing recognition of sleep apnea’s systemic impact, ...

In this week’s edition of InnovationRx, we look at a ‘holy grail’ pill for sleep apnea, Pomelo Care’s expansion, Nvidia and ...

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

This week, Mad in America examines recent antidepressant research questioning withdrawal severity, a study of unsupported ...

New research shows long-term sleep problems may change gut bacteria, increasing inflammation and health risks beyond the ...

Sleep apnea is increasingly common in India, yet few seek help. Factors like pollution and urban stress worsen sleep quality, leading to serious health risks.

AI can use sleep data from a single night to identify patterns linked to disease risk years before symptoms appear.